BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32252027)

  • 1. A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/- rats.
    Powers JF; Cochran B; Baleja JD; Sikes HD; Pattison AD; Zhang X; Lomakin I; Shepard-Barry A; Pacak K; Moon SJ; Langford TF; Stein KT; Tothill RW; Ouyang Y; Tischler AS
    Endocr Relat Cancer; 2020 Jun; 27(6):337-354. PubMed ID: 32252027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model systems in SDHx-related pheochromocytoma/paraganglioma.
    Takács-Vellai K; Farkas Z; Ősz F; Stewart GW
    Cancer Metastasis Rev; 2021 Dec; 40(4):1177-1201. PubMed ID: 34957538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting NAD
    Pang Y; Lu Y; Caisova V; Liu Y; Bullova P; Huynh TT; Zhou Y; Yu D; Frysak Z; Hartmann I; Taïeb D; Pacak K; Yang C
    Clin Cancer Res; 2018 Jul; 24(14):3423-3432. PubMed ID: 29636359
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
    Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
    Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Targeting of
    Liu Y; Pang Y; Zhu B; Uher O; Caisova V; Huynh TT; Taieb D; Hadrava Vanova K; Ghayee HK; Neuzil J; Levine M; Yang C; Pacak K
    Clin Cancer Res; 2020 Jul; 26(14):3868-3880. PubMed ID: 32152203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
    Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
    Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells.
    Richter S; D'Antongiovanni V; Martinelli S; Bechmann N; Riverso M; Poitz DM; Pacak K; Eisenhofer G; Mannelli M; Rapizzi E
    Cell Tissue Res; 2018 Dec; 374(3):473-485. PubMed ID: 30159755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
    Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
    Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
    Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
    J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and challenges in experimental models for pheochromocytoma and paraganglioma.
    Tischler AS; Favier J
    Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36810302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial function and content in pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers.
    Rapizzi E; Ercolino T; Canu L; Giaché V; Francalanci M; Pratesi C; Valeri A; Mannelli M
    Endocr Relat Cancer; 2012 Jun; 19(3):261-9. PubMed ID: 22323561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
    Oudijk L; Gaal J; de Krijger RR
    Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.
    Loriot C; Burnichon N; Gadessaud N; Vescovo L; Amar L; Libé R; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP; Favier J
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E954-62. PubMed ID: 22492777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
    Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma.
    Lepoutre-Lussey C; Thibault C; Buffet A; Morin A; Badoual C; Bénit P; Rustin P; Ottolenghi C; Janin M; Castro-Vega LJ; Trapman J; Gimenez-Roqueplo AP; Favier J
    Mol Cell Endocrinol; 2016 Feb; 421():40-8. PubMed ID: 26123588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
    Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
    Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.